newsfilter
← Latest News
GlobeNewswire·

POINT Biopharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights

INDIANAPOLIS, Nov. 13, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ:PNT) (the "Company" or "POINT"), a company accelerating the discovery, development, and global access to life-changing